Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Addiction Medicine
Research from University of London, Department of Mental Health Sciences broadens understanding of addiction medicine
May 18th, 2008
A new study, 'Neuropsychological predictors of clinical outcome in opiate addiction,' is now available. "A growing literature supports a role for neurocognitive deficits such as impaired decision-making in the development and maintenance of addictive behaviour. On the basis of these findings, it has been suggested that measures of neurocognitive functioning may be applied to the task of predicting clinical outcome in drug addiction," investigators in London, the United Kingdom report. "This in turn may have relevance for differentiating treatment based on individual patient needs. To explore this hypothesis we obtained neurocognitive measures of planning, impulsivity...
Source: Pharma Investments, Ventures & Law Weekly (2008-05-18)
|
